ReviewFrontiers in oncology2019
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics.
Danielle Golub et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
139 papers cite itlatest 60 shown
this paperpooled ittrialcites it